China Isotope & Radiation Corp
HKEX:1763
Intrinsic Value
The intrinsic value of one China Isotope & Radiation Corp stock under the Base Case scenario is 31.81 HKD. Compared to the current market price of 17.52 HKD, China Isotope & Radiation Corp is Undervalued by 45%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
Profitability Score
Profitability Due Diligence
China Isotope & Radiation Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
China Isotope & Radiation Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Isotope & Radiation Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
China Isotope & Radiation Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
China Isotope & Radiation Corp
| Current Assets | 7B |
| Cash & Short-Term Investments | 2.5B |
| Receivables | 3.2B |
| Other Current Assets | 1.2B |
| Non-Current Assets | 3.9B |
| Long-Term Investments | 851M |
| PP&E | 2.6B |
| Intangibles | 203M |
| Other Non-Current Assets | 266M |
| Current Liabilities | 4.2B |
| Accounts Payable | 488M |
| Accrued Liabilities | 3B |
| Other Current Liabilities | 788M |
| Non-Current Liabilities | 2.5B |
| Long-Term Debt | 202M |
| Other Non-Current Liabilities | 2.3B |
Capital Structure
China Isotope & Radiation Corp
| Market Capitalization | 5.6B HKD | |
| Total Debt | 202M HKD | |
| Minority Interest | 2B HKD | |
| Preferred Equity | 0 HKD | |
| Cash and Equivalents | 2.5B HKD | |
| Short-Term Investments | 0 HKD | |
| Enterprise Value | 5.3B HKD | |
Wall St
Price Targets
Price Targets Summary
China Isotope & Radiation Corp
According to Wall Street analysts, the average 1-year price target for China Isotope & Radiation Corp is 33.56 HKD .
Shareholder Return
Return Decomposition
Main factors of price return
Market capitalization of China Isotope & Radiation Corp shares decreased by 7.9% over the past 5 years. The primary factor behind the change was an increase in revenue growth from 4B to 5.7B, leading to a growth in the market capitalization of China Isotope & Radiation Corp by 34.36%.
Market capitalization of China Isotope & Radiation Corp shares decreased by 7.9% over the past 5 years. The primary factor behind the change was an increase in revenue growth from 4B to 5.7B, leading to a growth in the market capitalization of China Isotope & Radiation Corp by 34.36%.
Price
China Isotope & Radiation Corp
| Average Annual Return | 6.64% |
| Standard Deviation of Annual Returns | 32.63% |
| Max Drawdown | -63% |
| Market Capitalization | 5.6B HKD |
| Shares Outstanding | 319 874 900 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company is headquartered in Beijing, Beijing. The company went IPO on 2018-07-06. The firm also provides radiation sterilization services. The firm is also involved in the design, manufacture and installation of Gama ray irradiation devices. The firm opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.
Contact
IPO
Employees
Officers
The intrinsic value of one China Isotope & Radiation Corp stock under the Base Case scenario is 31.81 HKD.
Compared to the current market price of 17.52 HKD, China Isotope & Radiation Corp is Undervalued by 45%.
